These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21172105)

  • 61. Active surveillance: pitfalls to consider.
    Ercole B; Parekh DJ
    Arch Esp Urol; 2011 Oct; 64(8):695-702. PubMed ID: 22052752
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Implementation of PSA-based active surveillance in prostate cancer.
    Jalloh M; Cooperberg MR
    Biomark Med; 2014; 8(5):747-53. PubMed ID: 25123041
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Active surveillance for the secondary prevention of prostate cancer].
    Seisen T; Rouprêt M; Azzouzi AR; Cussenot O; Rozet F
    Prog Urol; 2012 Feb; 22(2 Suppl 1):H10-4. PubMed ID: 22445521
    [No Abstract]   [Full Text] [Related]  

  • 64. Innovations in prostate biopsy strategies for active surveillance and focal therapy.
    Ukimura O; Hung AJ; Gill IS
    Curr Opin Urol; 2011 Mar; 21(2):115-20. PubMed ID: 21178631
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Active surveillance of prostatic cancer].
    Vasarainen H; Ruutu M; Rannikko A
    Duodecim; 2011; 127(6):593-9. PubMed ID: 21528523
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Active surveillance for localized prostate cancer].
    Staerman F; Peyromaure M; Irani J; Gaschignard N; Mottet N; Soulié M; Salomon L;
    Prog Urol; 2011 Jul; 21(7):448-54. PubMed ID: 21693354
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Small renal mass and low-risk prostate cancer: any more for active surveillance?
    Yates DR; Rouprêt M
    Eur Urol; 2011 Jul; 60(1):45-7. PubMed ID: 21497435
    [No Abstract]   [Full Text] [Related]  

  • 68. Prostate cancer: A traffic-stopping prediction tool?
    Stone L
    Nat Rev Urol; 2014 Oct; 11(10):541. PubMed ID: 25155794
    [No Abstract]   [Full Text] [Related]  

  • 69. Point: active surveillance for favorable risk prostate cancer.
    Klotz L
    J Natl Compr Canc Netw; 2007 Aug; 5(7):693-8. PubMed ID: 17692173
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Managing prostate cancer. Part I: Localized disease.
    Edelstein RA; Babayan RK
    Hosp Pract (Off Ed); 1993 Apr; 28(4):61-4, 68-70, 75-8. PubMed ID: 7681843
    [No Abstract]   [Full Text] [Related]  

  • 71. [Prostate systematic biopsy].
    Kinoshita H; Matsuda T
    Nihon Rinsho; 2016 May; 74 Suppl 3():346-9. PubMed ID: 27344754
    [No Abstract]   [Full Text] [Related]  

  • 72. Canary Prostate Active Surveillance Study: design of a multi-institutional active surveillance cohort and biorepository.
    Newcomb LF; Brooks JD; Carroll PR; Feng Z; Gleave ME; Nelson PS; Thompson IM; Lin DW
    Urology; 2010 Feb; 75(2):407-13. PubMed ID: 19758683
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Biomarkers to guide therapy or surveillance for prostate cancer.
    Citrin D; Hudak K; Camphausen KA
    Biomark Med; 2013 Dec; 7(6):827-9. PubMed ID: 24266815
    [No Abstract]   [Full Text] [Related]  

  • 74. Use of Monitoring Tests Among Patients With Localized Prostate Cancer Managed With Observation. Letter.
    Shah N; Ioffe V
    J Urol; 2023 Aug; 210(2):247-248. PubMed ID: 37249551
    [No Abstract]   [Full Text] [Related]  

  • 75. Physical function before and after initial treatment among older adults with localized or regional stage prostate cancer.
    Qian J; Li C; Truong CB
    J Geriatr Oncol; 2022 Jan; 13(1):104-107. PubMed ID: 34246582
    [No Abstract]   [Full Text] [Related]  

  • 76. What's hot in the prostate?
    Belldegrun A
    Prostate Cancer Prostatic Dis; 2002; 5(2):84-7. PubMed ID: 12496994
    [No Abstract]   [Full Text] [Related]  

  • 77. Active surveillance not only reduces morbidity, It saves lives.
    Klotz L
    Oncology (Williston Park); 2013 Jun; 27(6):522, 593. PubMed ID: 23909063
    [No Abstract]   [Full Text] [Related]  

  • 78. Re: Prostate cancer antigen 3 score accurately predicts tumour volume and might help in selecting prostate cancer patients for active surveillance.
    Kakehi Y
    Eur Urol; 2011 Jul; 60(1):178-9. PubMed ID: 21640694
    [No Abstract]   [Full Text] [Related]  

  • 79. Re: Active Surveillance of Prostate Cancer in a Community Practice: How to Measure, Manage, and Improve?
    Penson DF
    J Urol; 2017 Mar; 197(3 Pt 1):703. PubMed ID: 28208525
    [No Abstract]   [Full Text] [Related]  

  • 80. Commentary on "The association between sexual function and prostate cancer risk in US veterans".
    Wang K; Cottler LB
    Asian J Androl; 2018; 20(1):99. PubMed ID: 28272056
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.